There is a critical need to improve adolescent vaccination rates. One of the goals of CDC's Healthy People 2010 initiative is to increase adolescent vaccine coverage to >90% within 5 years of the recommendation. Despite this, national coverage remains below this level. The state of Georgia has not met this goal for any of the four recommended vaccines for adolescents: Tdap, MCV4, HPV and influenza vaccine. This proposal assesses two potential interventions that could be used to increase adolescent vaccine coverage nationally. Specifically, we will determine whether a strategy of parent-only or a strategy of multicomponent parent and adolescent focused (teacher-delivered) intervention leads to higher immunization coverage. This design will allow us to determine the best means of reaching adolescents for vaccination. This has particular relevance since the number of adolescent vaccines has increased in recent years and is likely to continue to rise. We will conduct a three-armed controlled trial using a systematic balanced replication design to compare vaccination rates in Richmond County, a large, racially diverse county of eastern Georgia. We will randomly select 2 high schools and 3 middle schools to be in one of the three arms. In the first arm, we will implement two cycles of the parent-only intervention designed to motivate parents to have their adolescent vaccinated. In the second arm, we will implement two cycles of the multicomponent intervention targeting both parents and adolescents, through a teacher delivered intervention. In the third arm, we will implement no intervention. The primary outcome will be to estimate changes in adolescent vaccination coverage. Other outcomes will include the effect of the two interventions on mediators of vaccine acceptance. Findings from this study could have important policy implications, laying the foundation for portable and relevant educational interventions that have been shown to effectively increase adolescent immunizations.

Public Health Relevance

This proposal evaluates the efficacy of two influenza vaccine delivery strategies, a parent-only intervention and a multicomponent parent and adolescent focused, teacher-delivered, intervention, relative to a standard of care control group, in enhancing immunization rates among culturally diverse adolescents. It will also determine the minimum intervention necessary to increase immunizations.

Agency
National Institute of Health (NIH)
Institute
National Center for Immunication and Respiratory Diseases (NCIRD)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01IP000413-04
Application #
8527536
Study Section
Special Emphasis Panel (ZIP1-GCA (15))
Program Officer
Loveys, Deborah
Project Start
2010-09-01
Project End
2014-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
4
Fiscal Year
2013
Total Cost
$388,646
Indirect Cost
$55,604
Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Seib, Katherine; Underwood, Natasha L; Gargano, Lisa M et al. (2016) Preexisting Chronic Health Conditions and Health Insurance Status Associated With Vaccine Receipt Among Adolescents. J Adolesc Health 58:148-53
Gargano, Lisa M; Weiss, Paul; Underwood, Natasha L et al. (2015) School-Located Vaccination Clinics for Adolescents: Correlates of Acceptance Among Parents. J Community Health 40:660-9
Gargano, Lisa M; Underwood, Natasha L; Sales, Jessica M et al. (2015) Influence of sources of information about influenza vaccine on parental attitudes and adolescent vaccine receipt. Hum Vaccin Immunother 11:1641-7
Gargano, Lisa M; Herbert, Natasha L; Painter, Julia E et al. (2014) Development, theoretical framework, and evaluation of a parent and teacher-delivered intervention on adolescent vaccination. Health Promot Pract 15:556-67
Gargano, Lisa M; Herbert, Natasha L; Painter, Julia E et al. (2013) Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines. Hum Vaccin Immunother 9:2627-33